erlotinib hydrochloride has been researched along with succinic acid in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (succinic acid) | Trials (succinic acid) | Recent Studies (post-2010) (succinic acid) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 4,219 | 29 | 1,672 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | succinic acid (IC50) |
|---|---|---|---|
| Solute carrier family 13 member 3 | Homo sapiens (human) | 107 | |
| Egl nine homolog 1 | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desiraju, GR; Gopi, SP; Rajput, L; Sanphui, P | 1 |
1 other study(ies) available for erlotinib hydrochloride and succinic acid
| Article | Year |
|---|---|
New multi-component solid forms of anti-cancer drug Erlotinib: role of auxiliary interactions in determining a preferred conformation.
Topics: Adipates; Antineoplastic Agents; Crystallization; Crystallography, X-Ray; Erlotinib Hydrochloride; Glutarates; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Salts; Solubility; Succinic Acid; Urea | 2016 |